Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Automatic Data Processing vs. Lumentum: Which Technology Stock Is a Better Buy in 2026?

ADP offers steady dividend growth and record client satisfaction across a global payroll business. Lumentum is growing at a remarkable pace on AI demand but carries customer concentration risk worth understanding.

Automatic Data Processing vs. Lumentum: Which Technology Stock Is a Better Buy in 2026?

Published October 4, 2026 · Category: Finance

Overview

Investors often weigh steady dividend payers against high growth opportunities. Should you prioritize the stability of Automatic Data Processing (NASDAQ:ADP) or the aggressive expansion seen at Lumentum (NASDAQ:LITE) for your 2026 portfolio?

Automatic Data Processing provides critical human resources software for millions of workers, while Lumentum manufactures essential optical components for the artificial intelligence and telecommunications industries. These companies represent different risk profiles, with one offering a mature service model and the other targeting high-growth technological infrastructure.

Details

Automatic Data Processing provides cloud-based human capital management and payroll services to more than 1.1 million clients globally. The company holds a dominant market position, paying over 42 million workers across 140 different countries and territories. Its revenue is highly diversified, as no single client or group of affiliated clients accounts for more than 2% of annual consolidated revenues.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.